Insulin-like growth factor-I is an autocrine regulator of chromogranin a secretion and growth in human neuroendocrine tumor cells

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4573-4581

  Wichert, Götz Von ^a   Jehle, Peter M ^b   Hoeflich, Andreas ^c   Koschnick, Stefan ^a   Dralle, Henning ^e   Wolf, Eckhard ^c   Wiedenmann, Bertram ^d   Boehm, Bernhard O ^a   Adler, Guido ^a   Seufferlein, Thomas ^a  

^a Departments of Internal Medicine I   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c Department of Veterinary Medicine ^*  (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; CYCLIN D1; IODINE 125; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE C; S6 KINASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL CYCLE; CELL GROWTH; GASTRINOMA; GROWTH REGULATION; HUMAN; HUMAN CELL; INSULINOMA; NEUROENDOCRINE TUMOR; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TUMOR CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CARCINOID TUMOR; CELL ADHESION; CELL DIVISION; CHROMOGRANIN A; CHROMOGRANINS; CYCLIN D1; ENZYME ACTIVATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEUROENDOCRINE TUMORS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, IGF TYPE 1; RIBOSOMAL PROTEIN S6 KINASES; TUMOR CELLS, CULTURED;

EID: 0034662634     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. The neuroendocrine concept today
2. The human carcinoid cell line, BON. A model system for the study of carcinoid tumors
3. Gastrin is the most important factor in ECL tumourigenesis
4. Presence of nerve growth factor-like immunoreactivity in carcinoid tumour cells and induction of a neuronal phenotype in long-term culture
5. Expression of growth factor peptides and their receptors in neuroendocrine tumours of the digestive system
6. Presence of IGF-I in human midgut carcinoid tumours: An autocrine regulator of carcinoid tumour growth?
7. Insulin-like growth factor expression in human cancer cell lines
8. Insulin-like growth factor receptor expression and function in human breast cancer
9. Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain
10. The insulin-like growth factor I receptor: A key to tumor growth
11. The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts
12. Overexpression of insulin-like growth factor-I induces hyperplasia, dermal abnormalities, and spontaneous tumour formation in transgenic mice
13. The insulin-like growth factor-I receptor signaling pathways are important for tumourigenesis and inhibition of apoptosis
14. Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors
15. High affinity binding sites for proinsulin in human IM-9 lymphoblasts
16. The attractions of proteins for small molecules and ions
17. Heterogeneity of insulin-like growth factor binding proteins between structure and affinity. 2. Forms released by human and rat liver in culture
18. Protein measurement using bicinchoninic acid: Elimination of interfering substances
19. The insulin signaling system
20. TOR signaling and control of cell growth
21. Control of p70 s6 kinase by kinase activity of FRAP in vivo
22. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
23. s6k
24. Molecular and cell biological aspects of neuroendocrine tumours of the gastroenteropancreatic system
25. Effects of insulin-like growth factors I and II and insulin on the immortalized hypothalamic GTI-7 cell line
26. Rapid stimulation of fluid-phase endocytosis and exocytosis by insulin, insulin-like growth factor-I, and epidermal growth factor
27. Phorbol ester-induced alteration in the pattern of secretion and storage of chromogranin A and neurotensin in a human pancreatic carcinoid cell line
28. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production
29. Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: Potential role of MAP kinase and renaturable kinases
30. Possible involvement of phosphatidylinositol 3-kinase in regulated exocytosis: Studies in chromaffin cells with inhibitor LY 294002
31. Multiple protein kinase pathways are involved in gastrin-releasing peptide receptor-regulated secretion
32. Protein kinase C-δ is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation
33. The IGF-I receptor in cell growth, transformation and apoptosis
34. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small cell carcinoma of the lung
35. Transforming growth factor alpha activates Ha-ras in human pancreatic cancer cells with Ki-ras mutations
36. Cancer cell cycles
37. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention
38. Cyclins, and Cancer II. Cyclin D and CDK inhibitors come of age
39. Expression of IGFBP-2, -3 and -4 mRNA during differentiation of CaCo-2 colon epithelial cells
40. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumours
41. IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumourigenicity
42. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells
43. s6K pathway in human pancreatic cancer cells
44. s6K phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells
45. s6k-dependent pathway
46. Dedifferentiation of adenocarcinomas by activation of phosphoinositol 3-kinase
47. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase
48. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumourigenesis
49. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis
50. The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy